According to the Superintendent of the Hospital, Dr Dara Singh, a sample out of the batch of 16,750 vials of ampicillin, was found sub-standard by the Drug and Food Organisation.
"Generally a report from an accredited lab is accompanied with the medicine, but keeping in view the supply of spurious drugs in the state, whenever we receive any stock of drugs we ask the Drug and Food Organisation to pick the samples for the testing. In a similar exercise it was found that there was a problem with a batch of ampicillin injections," Singh told PTI.
They have also said that some foreign bodies were seen in the sample, Singh said.
This is the second drug this year which has been found as sub-standard.
Earlier, in April this year, the Drug Control Department through its testing laboratory revealed that Amoxicillin Trihydrate, manufactured in August 2012 had zero potency, and, hence, failed the test.
The Jammu and Kashmir government ordered separate probes by the Crime Branch and the Vigilance Department into the purchase and supply of spurious drugs in the state on April 20.
You’ve reached your limit of {{free_limit}} free articles this month.
Subscribe now for unlimited access.
Already subscribed? Log in
Subscribe to read the full story →
Smart Quarterly
₹900
3 Months
₹300/Month
Smart Essential
₹2,700
1 Year
₹225/Month
Super Saver
₹3,900
2 Years
₹162/Month
Renews automatically, cancel anytime
Here’s what’s included in our digital subscription plans
Exclusive premium stories online
Over 30 premium stories daily, handpicked by our editors


Complimentary Access to The New York Times
News, Games, Cooking, Audio, Wirecutter & The Athletic
Business Standard Epaper
Digital replica of our daily newspaper — with options to read, save, and share


Curated Newsletters
Insights on markets, finance, politics, tech, and more delivered to your inbox
Market Analysis & Investment Insights
In-depth market analysis & insights with access to The Smart Investor


Archives
Repository of articles and publications dating back to 1997
Ad-free Reading
Uninterrupted reading experience with no advertisements


Seamless Access Across All Devices
Access Business Standard across devices — mobile, tablet, or PC, via web or app
